Prof. Dr med. et Dr phil. Martin Buess

Swiss Society for Medical Oncology (SGMO)

Swiss Society of General Internal Medicine (SGAIM)

Swiss MD-PhD Association (SMPA)

Appius H, Hafer J, Harms W, Bolli M, Buess: Reproducibility of the CROSS-Trial Results in the Multimodal Treatment of Esophageal Cancer in Daily Practice: A Single Centre Retrospective Observational Study. M. J Oncol. 8955720. Rösch M, Bieg C, Savic S, Buess M: Androgen Deprivation Therapy for Intracranial Metastasis of a Salivary Duct Carcinoma: Case Report. Case Rep Oncol: 16 (1): 109-115.

Del Rio J, Buess M: Outcome of Hospitalised Cancer Patients with Hypernatremia: A Retrospective Case-Control Study. Curr Oncol. 29(11): 8814-8824 (2022).

• Rothschild SI, Zippelius A, Eboulet EI, Savic Prince S, Betticher D, Bettini A, Früh M, Joerger M, Lardinois D, Gelpke H, Mauti LA, Britschgi C, Weder W, Peters S, Mark M, Cathomas R, Ochsenbein AF, Janthur WD, Waibel C, Mach N, Froesch P, Buess M, Bohanes P, Godar G, Rusterholz C, Gonzalez M, Pless M: Swiss Group for Clinical Cancer Research (SAKK). SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicentre Single-Arm Phase II Trial. 2021: J Clin Oncol. 39(26):2872-2880.

Alborelli I, Leonards K, Rothschild SI, Leuenberger LP, Savic Prince S, Mertz KD, Poechtrager S, Buess M, Zippelius A, Läubli H, Haegele J, Tolnay M, Bubendorf L, Quagliata L, Jermann P. Tumour mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer. J Pathol. 2020 Jan;250(1):19-29. doi: 10.1002/path.5344. Epub 2019 Oct 24. PMID: 31471895; PMCID: PMC6972587

Wallrabenstein T, Del Rio J, Templeton AJ, Buess M (2020) Much has changed in the last decade except overall survival: A Swiss single centre analysis of treatment and survival in patients with stage IV non-small cell lung cancer. PLoS ONE 15(5): e0233768. https://doi. org/10.1371/journal.pone.0233768

Ferraro DA, Patella F, Zanivan S, Donato C, Aceto N, Giannotta M, Dejana E, Diepenbruck M, Christofori G, Buess M; Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells. BMC Cancer. 2019 Apr 4; 19(1): 312.